The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. ...

Over the last three decades, 40 states have legalized the sale and use of medical marijuana in one form or another. Last week, the federal government followed suit, and the policy change could have ...

By Puyaan Singh and Christy Santhosh April 30 (Reuters) - Companies developing cannabis-based medicines say U.S. moves to ...

This change frees researchers to study cannabis products that most consumers encounter when buying medical marijuana – which ...

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

The Trump administration is reclassifying state-licensed medical marijuana as a less dangerous drug. Local providers say the ...

The DEA announced the new requirements for medical marijuana dispensaries seeking federal compliance, including application ...

Dr. Francesca Filbey, a professor of psychology at the University of Texas at Dallas, has studied the effects of cannabis on ...

The U.S. Department of Justice (DOJ) has reclassified certain marijuana and marijuana-containing products to Schedule III ...

The federal government reclassified marijuana from Schedule I to Schedule III, impacting Oklahoma's medical marijuana ...